Janus Henderson Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $575K | Hold |
49,688
| – | – | ﹤0.01% | 1876 |
|
2025
Q1 | $455K | Hold |
49,688
| – | – | ﹤0.01% | 2003 |
|
2024
Q4 | $714K | Hold |
49,688
| – | – | ﹤0.01% | 1856 |
|
2024
Q3 | $1.12M | Hold |
49,688
| – | – | ﹤0.01% | 1605 |
|
2024
Q2 | $965K | Buy |
49,688
+10,888
| +28% | +$211K | ﹤0.01% | 1637 |
|
2024
Q1 | $1.46M | Hold |
38,800
| – | – | ﹤0.01% | 1438 |
|
2023
Q4 | $2.17M | Sell |
38,800
-23
| -0.1% | -$1.29K | ﹤0.01% | 1213 |
|
2023
Q3 | $1.6M | Buy |
38,823
+12
| +0% | +$495 | ﹤0.01% | 1302 |
|
2023
Q2 | $2.17M | Sell |
38,811
-49
| -0.1% | -$2.74K | ﹤0.01% | 1201 |
|
2023
Q1 | $2.17M | Buy |
38,860
+23,881
| +159% | +$1.33M | ﹤0.01% | 1210 |
|
2022
Q4 | $546K | Sell |
14,979
-14,979
| -50% | -$546K | ﹤0.01% | 1661 |
|
2022
Q3 | $854K | Buy |
29,958
+13,079
| +77% | +$373K | ﹤0.01% | 1727 |
|
2022
Q2 | $764K | Sell |
16,879
-39,232
| -70% | -$1.78M | ﹤0.01% | 1492 |
|
2022
Q1 | $4.27M | Sell |
56,111
-201,499
| -78% | -$15.3M | ﹤0.01% | 1045 |
|
2021
Q4 | $38.4M | Buy |
257,610
+222,183
| +627% | +$33.1M | 0.02% | 627 |
|
2021
Q3 | $5.16M | Buy |
35,427
+31,529
| +809% | +$4.59M | ﹤0.01% | 1044 |
|
2021
Q2 | $764K | Buy |
+3,898
| New | +$764K | ﹤0.01% | 1363 |
|
2021
Q1 | – | Sell |
-36,192
| Closed | -$5.13M | – | 1629 |
|
2020
Q4 | $5.13M | Buy |
+36,192
| New | +$5.13M | ﹤0.01% | 956 |
|
2019
Q4 | – | Sell |
-28,481
| Closed | -$1.44M | – | 1465 |
|
2019
Q3 | $1.44M | Buy |
+28,481
| New | +$1.44M | ﹤0.01% | 1189 |
|